Melanoma

"Melanoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Descriptor ID	D008545
MeSH Number(s)	C04.557.465.625.650.510 C04.557.580.625.650.510 C04.557.665.510
Concept/Terms	Melanoma Melanoma Melanomas Malignant Melanoma Malignant Melanomas Melanoma, Malignant Melanomas, Malignant

Below are MeSH descriptors whose meaning is more general than "Melanoma".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Germ Cell and Embryonal [C04.557.465]
Neuroectodermal Tumors [C04.557.465.625]
Neuroendocrine Tumors [C04.557.465.625.650]
Melanoma [C04.557.465.625.650.510]
Neoplasms, Nerve Tissue [C04.557.580]
Neuroectodermal Tumors [C04.557.580.625]
Neuroendocrine Tumors [C04.557.580.625.650]
Melanoma [C04.557.580.625.650.510]
Nevi and Melanomas [C04.557.665]
Melanoma [C04.557.665.510]

Below are MeSH descriptors whose meaning is related to "Melanoma".

Below are MeSH descriptors whose meaning is more specific than "Melanoma".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Melanoma" by people in this website by year, and whether "Melanoma" was a major or minor topic of these publications.

Bar chart showing 926 publications over 30 distinct years, with a maximum of 48 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	30	0	30
1997	15	1	16
1998	28	4	32
1999	19	3	22
2000	21	1	22
2001	20	2	22
2002	27	3	30
2003	15	4	19
2004	13	2	15
2005	18	2	20
2006	14	7	21
2007	29	6	35
2008	30	3	33
2009	31	1	32
2010	27	6	33
2011	30	8	38
2012	34	9	43
2013	43	1	44
2014	33	4	37
2015	36	7	43
2016	32	2	34
2017	35	1	36
2018	35	2	37
2019	47	1	48
2020	39	5	44
2021	44	2	46
2022	24	1	25
2023	37	1	38
2024	27	0	27
2025	4	0	4

Below are the most recent publications written about "Melanoma" by people in Profiles.

Shields CL, Suribhatla R, Romero M, Ealer C, Bansal R, Emrich J, Komarnicky-Kocher L, Lally SE. TISSUE GLUE-ASSISTED PLAQUE RADIOTHERAPY FOR CHOROIDAL TUMORS WITH SCLERAL THINNING. Retina. 2025 04 01; 45(4):675-682.

View in: PubMed
Varney SD, Erkes DA, Mersky GL, Mustafa MU, Chua V, Chervoneva I, Purwin TJ, Alnemri E, Aplin AE. Metabolic Inhibition Induces Pyroptosis in Uveal Melanoma. Mol Cancer Res. 2025 Apr 01; 23(4):350-362.

View in: PubMed
Yu MD, Heiferman M, Korot E, Ahluwalia A, Yu G, Mruthyunjaya P. Pixel Intensity to Estimate Choroidal Tumor Thickness Using 2-Dimensional Ultra-Widefield Images. JAMA Ophthalmol. 2025 Mar 01; 143(3):236-240.

View in: PubMed
Lubrano S, Cervantes-Villagrana RD, Faraji F, Ramirez S, Sato K, Adame-Garcia SR, Officer A, Arang N, Rigiracciolo DC, Anguiano Quiroz PY, Martini C, Wang Y, Ferguson FM, Bacchiocchi A, Halaban R, Coma S, Holmen SL, Pachter JA, Aplin AE, Gutkind JS. FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma. Cancer Cell. 2025 Mar 10; 43(3):428-445.e6.

View in: PubMed
Cappelli L, Khan MM, Shields CL, Lally SE, Sharif M, Liu H, Chen Y, Park J, Zhan T, Shi W. Favorable Outcomes of Patients With High-Risk Uveal Melanoma Treated With a Novel Linear Accelerator-Based Frameless Fractionated Stereotactic Radiosurgery. Am J Ophthalmol. 2025 Mar; 271:417-423.

View in: PubMed
Dimitriou F, Orloff MM, Koch Hein EC, Cheng PF, Hughes IF, Simeone E, Montazeri K, Grover P, Mehmi I, Gerard CL, Gaudy-Marqueste C, Grob JJ, Michielin O, Hamid O, Long GV, Sullivan R, Kapiteijn E, Johnson DB, Ascierto PA, Joshua AM, Carvajal RD, Butler MO, Hassel JC, Dummer R. Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. Eur J Cancer. 2025 Jan; 214:115161.

View in: PubMed
Gandarillas S, Berger A, Stephenson R, Mehregan D, Dasgeb B. Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid. Int J Dermatol. 2025 Feb; 64(2):399-401.

View in: PubMed
Sener H, Bansal R, Catapano T, Shields JA, Shields CL. Non-Conditional and Conditional Metastasis of Uveal Melanoma Per Millimeter-By-Millimeter in Thickness in 8034 Patients. Semin Ophthalmol. 2025 Oct; 40(7):642-649.

View in: PubMed
Hlavaty SI, Salcido KN, Pniewski KA, Mukha D, Ma W, Kannan T, Cassel J, Srikanth YVV, Liu Q, Kossenkov A, Salvino JM, Chen Q, Schug ZT. ACSS1-dependent acetate utilization rewires mitochondrial metabolism to support AML and melanoma tumor growth and metastasis. Cell Rep. 2024 12 24; 43(12):114988.

View in: PubMed
Mandloi S, Gargano SM, Duffy AN, Benedict PA, Shing SR, Kahn C, Hannikainen P, Pineda-Reyes JP, Bray D, Toskala EM, Rabinowitz M, Rosen M, Farrell C, Evans JJ, Nyquist GG. The Presence of Pigment Incontinence in Sinonasal Mucosal Melanoma. Laryngoscope. 2025 Apr; 135(4):1321-1325.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement